<unk>  (FFA) is a member of the anthranilic acid derivatives (or fenamate) class of nonsteroidal anti-inflammatory drugs (NSAIDs). Like other members of the class, it is a cyclooxygenase (COX) inhibitor, preventing the formation of prostaglandins. FFA is known to bind to and reduce the activity of prostaglandin F synthase and activate TRPC6. It is not widely used in humans as it has a high rate (30–60%) of gastrointestinal side effects. It is generally not available in the US. It is available in some Asian and European countries as a generic drug. Scientists led by Claude Winder from Parke-Davis invented FFA in 1963, along with fellow members of the class, mefenamic acid in 1961 and meclofenamic acid in 1964. Although<unk>  was at one time informally referred to as "Fluffy" (see history cache), this pet name could also refer to flufenoxine.
Flufenamic acid
Enoxaparin sodium
Heparin
Tranexamic acid
Mefenamic acid
Palladin
Apixaban
Tinzaparin sodium